60 results
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
, bank information, or customer or account number; (ii) any information which would qualify as “personally identifiable” information as applied
424B5
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Prospectus supplement for primary offering
4:53pm
interests in a global security held through participants will be governed by standing customer instructions and customary practices, as is now the case
425
549euviupvcxmj4u1r
5 Jul 22
Business combination disclosure
7:14am
8-K
EX-2.1
bg41xwdd
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
8-K
EX-10.4
52vmcki5 dj
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
8-K
EX-10.1
gz5ib7ul6quq8kc4n
13 Oct 21
Departure of Directors or Certain Officers
4:01pm